Position in AGIO
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$79,968,339
-$11,538,428 QoQ
Shares Held
2,154,900
-20.3% QoQ
Ownership
3.62%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#1
of 35 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Erste Asset Management GmbH holds $553,204,959 across 68 Biotechnology names. AGIO ranks #1 (14.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AGIO |
Agios Pharmaceuticals, Inc.
This page
|
2,154,900 | $79,968,339 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
110,210 | $59,177,259 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
2,568,945 | $46,163,941 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
76,558 | $38,028,654 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
834,000 | $29,515,260 | |
| 6 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
2,536,939 | $25,141,065 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,716 | $24,140,974 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
205,000 | $23,999,350 |
All Filings in AGIO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $79,968,339 | 2,154,900 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $91,506,767 | 2,704,900 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $76,349,378 | 2,804,900 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $110,983,086 | 2,764,900 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $77,379,024 | 2,326,489 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $65,336,070 | 2,229,900 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $66,045,314 | 2,009,900 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $97,075,107 | 2,184,900 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $97,231,288 | 2,254,900 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $66,664,276 | 2,279,900 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $46,942,933 | 2,107,900 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $41,931,450 | 1,694,200 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $47,979,744 | 1,694,200 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $38,915,774 | 1,694,200 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $47,573,136 | 1,694,200 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $47,911,976 | 1,694,200 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $38,336,364 | 1,729,200 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $47,426,012 | 1,629,200 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $51,875,434 | 1,578,200 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $52,758,680 | 1,143,200 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $59,733,729 | 1,083,900 | Shares | Sole | 2024-11-25 | |
| 2021-03-31 | $54,423,396 | 1,053,900 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $45,665,487 | 1,053,900 | Shares | Sole | 2024-11-25 | |
| 2020-09-30 | $34,562,500 | 987,500 | Shares | Sole | 2024-11-25 | |
| 2020-06-30 | $48,672,148 | 910,100 | Shares | Sole | 2024-11-22 | |
| 2020-03-31 | $36,735,992 | 1,035,400 | Shares | Sole | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||